ResearcherEssen University HospitalActive in the last 2 years
Erich Gulbins
Matched on ORCID iD 0000-0002-3117-1342; OpenAlex author ID A5041073789. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreati… Co-author DOI 10.1016/j.phrs.2026.108150↗
- Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in v… Last author DOI 10.1007/s00109-023-02290-y↗
- Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00109-023-02331-6↗
- Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunoc… Co-author DOI 10.3390/cancers14112618↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ildikò Szabó · 4 shared papers, 2022–2026 · strength 0.71
- Paper Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B re… DOI 10.1016/j.phrs.2026.108150↗
- Paper Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma. DOI 10.1007/s00109-023-02331-6↗
- Paper Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ducta… DOI 10.1007/s00109-023-02290-y↗
- Gregory C. Wilson · 3 shared papers, 2022–2023 · strength 0.48
- Paper Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma. DOI 10.1007/s00109-023-02331-6↗
- Paper Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ducta… DOI 10.1007/s00109-023-02290-y↗
- Paper Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancre… DOI 10.3390/cancers14112618↗
- Sameer H. Patel · 3 shared papers, 2022–2023 · strength 0.48
- Paper Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma. DOI 10.1007/s00109-023-02331-6↗
- Paper Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ducta… DOI 10.1007/s00109-023-02290-y↗
- Paper Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancre… DOI 10.3390/cancers14112618↗
- Syed Ameen Ahmad · 2 shared papers, 2022–2023 · strength 0.30
- Paper Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ducta… DOI 10.1007/s00109-023-02290-y↗
- Paper Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancre… DOI 10.3390/cancers14112618↗
- Sofia Parrasia · 1 shared paper, 2026 · strength 0.23
- Vincenzo Corbo · 1 shared paper, 2026 · strength 0.23
- Lucia Biasutto · 1 shared paper, 2026 · strength 0.23
- Alessandro Carrer · 1 shared paper, 2026 · strength 0.23
- Elena Fiorini · 1 shared paper, 2026 · strength 0.23
- Carlotta Paoli · 1 shared paper, 2026 · strength 0.23
- Kevin M. Turner · 1 shared paper, 2023 · strength 0.18
- Syed Arif Ahmad · 1 shared paper, 2023 · strength 0.18
- Weiwei Li · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.